niacin has been researched along with Hypertension in 53 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This was a pragmatic comparative effectiveness study carried out at 110 centers across China in outpatients with primary hypertension treated with levoamlodipine maleate or amlodipine besylate, with 24 months of follow-up." | 9.41 | Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study. ( Chen, P; Cui, L; Cui, W; Dang, A; Dong, Y; Du, X; Duan, C; Gao, P; Hua, Q; Huo, Y; Jiang, Y; Li, J; Ma, W; Qi, X; Qu, P; Sun, N; Sun, Y; Wu, G; Xie, J; Zhao, L, 2021) |
| "The objective of this study was to observe the antihypertensive effect of losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension (EH) combined with isolated impaired fasting glucose (i-IFG)." | 9.22 | Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose. ( Jiang, XS; Liu, L; Ning, N; Tan, MH; Wei, P; Xiao, WY; Yi, D; Zhou, L, 2016) |
| "This exploratory study compared the amount of pedal edema experienced by female Korean patients with mild to moderate hypertension when receiving S(-)-amlodipine nicotinate compared with amlodipine besylate." | 9.16 | Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical ( Choi, DJ; Kang, HJ; Lee, HY; Oh, BH; Oh, GC; Zo, JH, 2012) |
| " To increase the probability of flushing, subjects were administered niacin ER at the upper limit of the approved dosage range (2,000 mg), and were precluded from using aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) during the study." | 9.12 | Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. ( Cefali, EA; Shamp, TR; Simmons, PD; Stanek, EJ, 2006) |
| "The relationship of dietary niacin intake with the risk of hypertension remains unknown." | 8.02 | Evaluation of Dietary Niacin and New-Onset Hypertension Among Chinese Adults. ( He, P; Li, H; Li, Q; Liu, C; Liu, M; Qin, X; Zhang, Y; Zhang, Z; Zhou, C, 2021) |
| "This was a pragmatic comparative effectiveness study carried out at 110 centers across China in outpatients with primary hypertension treated with levoamlodipine maleate or amlodipine besylate, with 24 months of follow-up." | 5.41 | Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study. ( Chen, P; Cui, L; Cui, W; Dang, A; Dong, Y; Du, X; Duan, C; Gao, P; Hua, Q; Huo, Y; Jiang, Y; Li, J; Ma, W; Qi, X; Qu, P; Sun, N; Sun, Y; Wu, G; Xie, J; Zhao, L, 2021) |
| "The objective of this study was to observe the antihypertensive effect of losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension (EH) combined with isolated impaired fasting glucose (i-IFG)." | 5.22 | Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose. ( Jiang, XS; Liu, L; Ning, N; Tan, MH; Wei, P; Xiao, WY; Yi, D; Zhou, L, 2016) |
| "This exploratory study compared the amount of pedal edema experienced by female Korean patients with mild to moderate hypertension when receiving S(-)-amlodipine nicotinate compared with amlodipine besylate." | 5.16 | Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical ( Choi, DJ; Kang, HJ; Lee, HY; Oh, BH; Oh, GC; Zo, JH, 2012) |
| " To increase the probability of flushing, subjects were administered niacin ER at the upper limit of the approved dosage range (2,000 mg), and were precluded from using aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) during the study." | 5.12 | Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. ( Cefali, EA; Shamp, TR; Simmons, PD; Stanek, EJ, 2006) |
| "The relationship of dietary niacin intake with the risk of hypertension remains unknown." | 4.02 | Evaluation of Dietary Niacin and New-Onset Hypertension Among Chinese Adults. ( He, P; Li, H; Li, Q; Liu, C; Liu, M; Qin, X; Zhang, Y; Zhang, Z; Zhou, C, 2021) |
| " The multiple adjusted odds ratios (95% confidence interval) of having microalbuminuria per 1 standard deviation increase in total protein (%kcal), animal protein (%kcal), animal protein (g/day), animal fat, niacin, carbohydrate and β-cryptoxanthin among the women were 1." | 3.78 | Relationship between dietary intake and microalbuminuria: findings from the Takahata study. ( Fukao, A; Hozawa, A; Kato, T; Kayama, T; Konta, T; Kubota, I; Narimatsu, H; Otani, K; Sasaki, S; Sato, M; Shao, L; Yamashita, H, 2012) |
| "Results of recent clinical trials on secondary prevention of ischemic heart disease indicate that judicious, long-term administration of adrenergic beta blockers and platelet-active drugs such as aspirin and Persantine (dipyridamole) would seem to yield protection against mortality associated with acute myocardial infarction, including sudden death." | 3.67 | Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. ( Borhani, NO, 1985) |
| "Hypertension is a serious global public health issue." | 1.91 | Antihypertensive activity of different components of Veratrum alkaloids through metabonomic data analysis. ( Chen, J; Cong, Y; Cui, Y; Guo, J; Jin, T; Wang, H; Yu, R; Zhao, R; Zhou, Z, 2023) |
| "Niacin is an effective lipid-altering agent that has been reported to reduce the risk of cardiovascular disease." | 1.35 | Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: a post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients. ( Bays, HE; Kuznetsova, O; Maccubbin, D; Meehan, AG; Mitchel, YB; Paolini, JF, 2009) |
| " However, the existence of a dose-response relationship, with increasing amounts of ingestion resulting in more severe symptoms, needs further observation and studies that include a larger series." | 1.30 | Acute poisoning with a herbicide containing imazapyr (Arsenal): a report of six cases. ( Chen, KW; Lee, HL; Wu, MH, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (47.17) | 18.7374 |
| 1990's | 4 (7.55) | 18.2507 |
| 2000's | 9 (16.98) | 29.6817 |
| 2010's | 12 (22.64) | 24.3611 |
| 2020's | 3 (5.66) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Z | 1 |
| Chen, J | 1 |
| Cui, Y | 1 |
| Zhao, R | 1 |
| Wang, H | 1 |
| Yu, R | 1 |
| Jin, T | 1 |
| Guo, J | 1 |
| Cong, Y | 1 |
| Lu, Y | 1 |
| Yin, J | 1 |
| Wu, X | 1 |
| Fan, Y | 1 |
| Liu, F | 1 |
| Ma, W | 1 |
| Sun, N | 1 |
| Duan, C | 1 |
| Zhao, L | 2 |
| Hua, Q | 1 |
| Sun, Y | 1 |
| Dang, A | 1 |
| Gao, P | 1 |
| Qu, P | 1 |
| Cui, W | 1 |
| Dong, Y | 1 |
| Cui, L | 1 |
| Qi, X | 1 |
| Jiang, Y | 1 |
| Xie, J | 1 |
| Li, J | 1 |
| Wu, G | 1 |
| Du, X | 1 |
| Huo, Y | 1 |
| Chen, P | 1 |
| Zhang, Z | 1 |
| Liu, M | 1 |
| Zhou, C | 1 |
| He, P | 1 |
| Zhang, Y | 1 |
| Li, H | 1 |
| Li, Q | 1 |
| Liu, C | 1 |
| Qin, X | 1 |
| Skolnik, N | 1 |
| Jaffa, FM | 1 |
| Kalyani, RR | 1 |
| Johnson, E | 1 |
| Shubrook, JH | 1 |
| Haneef, J | 1 |
| Chadha, R | 2 |
| DAL PALU, C | 2 |
| RIZZI, R | 2 |
| BERETTA, A | 1 |
| Wang, Z | 1 |
| Yang, L | 1 |
| Cui, S | 1 |
| Liang, Y | 1 |
| Zhang, X | 1 |
| Bhandari, S | 1 |
| Khullar, S | 1 |
| Mandal, SK | 1 |
| Jain, DV | 1 |
| Verdoia, M | 1 |
| Schaffer, A | 1 |
| Suryapranata, H | 1 |
| De Luca, G | 1 |
| Misra, A | 1 |
| Bhardwaj, S | 1 |
| Xiao, WY | 1 |
| Ning, N | 1 |
| Tan, MH | 1 |
| Jiang, XS | 1 |
| Zhou, L | 1 |
| Liu, L | 1 |
| Yi, D | 1 |
| Wei, P | 1 |
| Rahimy, E | 1 |
| Gaynon, MW | 1 |
| Paulus, YM | 1 |
| Alexander, JL | 1 |
| Mansour, SE | 1 |
| Bays, HE | 2 |
| Rader, DJ | 1 |
| Maccubbin, D | 1 |
| Meehan, AG | 1 |
| Kuznetsova, O | 1 |
| Mitchel, YB | 1 |
| Paolini, JF | 1 |
| Cho, KH | 1 |
| Kim, HJ | 1 |
| Rodriguez-Iturbe, B | 1 |
| Vaziri, ND | 1 |
| Sato, M | 1 |
| Hozawa, A | 1 |
| Konta, T | 1 |
| Shao, L | 1 |
| Otani, K | 1 |
| Narimatsu, H | 1 |
| Sasaki, S | 1 |
| Kato, T | 1 |
| Kubota, I | 1 |
| Yamashita, H | 1 |
| Kayama, T | 1 |
| Fukao, A | 1 |
| Oh, GC | 1 |
| Lee, HY | 1 |
| Kang, HJ | 1 |
| Zo, JH | 1 |
| Choi, DJ | 1 |
| Oh, BH | 1 |
| Doskina, EV | 1 |
| Gadegbeku, CA | 1 |
| Dhandayuthapani, A | 1 |
| Shrayyef, MZ | 1 |
| Egan, BM | 1 |
| Talbert, RL | 1 |
| Pieper, JA | 1 |
| Ito, MK | 1 |
| SKURSKY, J | 1 |
| IAKOVLEVA-KORCHAGINA, IN | 1 |
| MATHIEU, L | 1 |
| REMY, M | 1 |
| PERNOT, C | 1 |
| MARUEJOL, M | 1 |
| NUSSBAUM, HE | 1 |
| LEFF, W | 1 |
| MATTIA, VD | 1 |
| HILLMAN, E | 1 |
| HALLWRIGHT, GP | 1 |
| FUJIHARA, M | 1 |
| TAKAHASHI, I | 1 |
| HAYASHI, K | 1 |
| TANAKA, M | 1 |
| WEINER, M | 1 |
| KOBAYASHI, T | 1 |
| TAKEUCHI, M | 1 |
| KOJIMA, K | 1 |
| BERETTAANGUISSOLA, A | 1 |
| FERUGLIO, FS | 1 |
| CORSI, V | 1 |
| TEDESCHI, A | 1 |
| GIOFFRE, M | 1 |
| BASILE, U | 1 |
| SPAZIANTE, G | 1 |
| FRATELLO, U | 1 |
| TADROS, FW | 1 |
| HIGAZI, AM | 1 |
| ZAKI, SA | 1 |
| GONZALEZ, O | 1 |
| SCHOEN, H | 1 |
| NEUMANN, J | 1 |
| MENEGHINI, P | 1 |
| AVANZI, G | 1 |
| VALLSSERRA, J | 1 |
| DEGREGORIO, G | 1 |
| BUDA, A | 1 |
| FIDECARO, A | 1 |
| MACCARINI, PA | 1 |
| FREZZA, S | 1 |
| BARICALLA, A | 1 |
| Ashen, MD | 1 |
| Blumenthal, RS | 1 |
| Cefali, EA | 1 |
| Simmons, PD | 1 |
| Stanek, EJ | 1 |
| Shamp, TR | 1 |
| Andrews, TC | 1 |
| Whitney, EJ | 1 |
| Green, G | 1 |
| Kalenian, R | 1 |
| Personius, BE | 1 |
| Lee, HL | 1 |
| Chen, KW | 1 |
| Wu, MH | 1 |
| Smolenskaia, OG | 1 |
| Kazakov, IaE | 1 |
| Barats, SS | 1 |
| Rudzite, V | 1 |
| Sileniece, G | 1 |
| Liepina, D | 1 |
| Dalmane, A | 1 |
| Zirne, R | 1 |
| Borhani, NO | 1 |
| Fregly, MJ | 1 |
| Lockley, OE | 1 |
| Torres, JL | 1 |
| Cade, JR | 1 |
| Cunha, DF | 1 |
| Monteiro, JP | 1 |
| Ortega, LS | 1 |
| Alves, LG | 1 |
| Cunha, SF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Levamlodipine Maleate (Xuanning) or Amlodipine Besylate (Norvasc) for Treatment of Hypertension: A Comparative Effectiveness Research[NCT01844570] | 10,000 participants (Anticipated) | Observational | 2013-02-28 | Active, not recruiting | |||
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| Hypertension Management and Outcomes in a Family Practice Setting[NCT03579108] | 200 participants (Anticipated) | Observational | 2018-02-24 | Recruiting | |||
| A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the Lipid-Altering Efficacy, Safety and Tolerability of MK0524A in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia[NCT00269204] | Phase 3 | 1,620 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| Treatment Study for Severe High-Density Lipoprotein Deficiency[NCT00458055] | 19 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Effect of Tomato Consumption on Serum High Density Lipoprotein-cholesterol Levels. A Randomized, Open-label, Single Blind, Clinical Trial[NCT01342666] | 50 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluate the effect of two daily tomatoes consumption on HDL-c levels. (NCT01342666)
Timeframe: Baseline and after one month
| Intervention | mg/dL (Mean) | |
|---|---|---|
| Baseline HDL-c | Final HDL-c | |
| Cucumber Consumption | 36.8 | 35.8 |
| Tomato Consumption | 36.5 | 41.6 |
3 reviews available for niacin and Hypertension
| Article | Year |
|---|---|
Effects of HDL-modifiers on cardiovascular outcomes: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Diabetes Mel | 2015 |
Does nicotinic acid (niacin) lower blood pressure?
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Niacin | 2009 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
7 trials available for niacin and Hypertension
| Article | Year |
|---|---|
Comparative effects of 2.5mg levamlodipine and 5mg amlodipine on vascular endothelial function and atherosclerosis.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atherosclerosis; Endothelium, Vascular | 2019 |
Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; China; | 2021 |
Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Essential Hypertension; F | 2016 |
Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response R | 2012 |
Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects.
Topics: Adult; Blood Pressure; Compliance; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Hypertens | 2003 |
Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Body Mass Index; Cross-Over Studies; Delayed-Action P | 2006 |
Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl.
Topics: Aged; Brachial Artery; Cholestyramine Resin; Coronary Disease; Double-Blind Method; Drug Therapy, Co | 1997 |
43 other studies available for niacin and Hypertension
| Article | Year |
|---|---|
Antihypertensive activity of different components of Veratrum alkaloids through metabonomic data analysis.
Topics: Animals; Antihypertensive Agents; Data Analysis; Humans; Hypertension; Niacin; Niacinamide; Rats; Ve | 2023 |
Evaluation of Dietary Niacin and New-Onset Hypertension Among Chinese Adults.
Topics: Adult; Blood Pressure; China; Cross-Sectional Studies; Diet; Female; Humans; Hypertension; Male; Mid | 2021 |
Reducing CV risk in diabetes: An ADA update.
Topics: Antihypertensive Agents; Aspirin; Benzhydryl Compounds; Cardiovascular Diseases; Contraindications; | 2017 |
Antioxidant-Based Eutectics of Irbesartan: Viable Multicomponent Forms for the Management of Hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Biphenyl Compounds; Calorimetry, Diff | 2018 |
[Hemodynamic modifications from nicotinic acid in hypertension].
Topics: Blood Pressure; Blood Pressure Determination; Humans; Hypertension; Niacin; Nicotinic Acids | 1950 |
[Arterial tension reaction. II. Adrenalin, pituitrin, aminophylline, acetylcholine and nicotinic acid tests].
Topics: Acetylcholine; Aminophylline; Blood Pressure; Blood Pressure Determination; Epinephrine; Humans; Hyp | 1951 |
Synthesis and anti-hypertensive effects of the twin drug of nicotinic acid and quercetin tetramethyl ether.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Ethers; Hypertension; Male; | 2014 |
Characterization and evaluation of multi-component crystals of hydrochlorothiazide.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Crystallization; Female; Hydrochlorothiazide; Hype | 2014 |
(8) Cardiovascular disease and risk management.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Diabetes | 2015 |
(8) Cardiovascular disease and risk management.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Diabetes | 2015 |
(8) Cardiovascular disease and risk management.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Diabetes | 2015 |
(8) Cardiovascular disease and risk management.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Diabetes | 2015 |
Management of the Metabolic Syndrome and the Obese Patient with Metabolic Disturbances: South Asian Perspective.
Topics: Adipose Tissue; Asia; Asian People; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Dietar | 2015 |
Potentially Reversible Effect of Niacin Therapy on Edema From Retinal Vein Occlusion.
Topics: Administration, Oral; Humans; Hyperlipidemias; Hypertension; Macular Edema; Male; Middle Aged; Niaci | 2016 |
Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: a post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Clinical Trials, Phase III as Topic; Delayed-Action | 2009 |
Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.
Topics: Animals; Chemokine CCL2; Creatinine; Disease Models, Animal; Hypertension; Inflammation; Kidney Fail | 2009 |
Relationship between dietary intake and microalbuminuria: findings from the Takahata study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Asian People; Creatinine; Cryptoxanthins; Diet Surveys; | 2012 |
[A case of familial restrictive cardiomyopathy].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Atenolol; Atrial Fibrillation | 2002 |
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studies.
Topics: Aspirin; Atenolol; Blood Chemical Analysis; Coronary Disease; Female; Humans; Hyperlipidemias; Hyper | 2003 |
[Results in therapy of essential hypertension and cerebral sclerosis with mutan].
Topics: Arteriosclerosis; Brain; Essential Hypertension; Humans; Hypertension; Niacin; Nicotinic Acids; Tube | 1953 |
[Effect of nicotinic acid on cholesterinemia in hypertension].
Topics: Blood; Cholesterol; Humans; Hypertension; Niacin; Nicotinic Acids | 1952 |
[The carotid piesogram in arterial hypertension].
Topics: Arteries; Blood Pressure; Blood Pressure Determination; Carotid Arteries; Humans; Hypertension; Niac | 1954 |
The effects of iproniazid phosphate (marsilid) on hypertension.
Topics: Hypertension; Iproniazid; Niacin; Nicotinic Acids; Phosphates | 1957 |
Iproniazid in the treatment of hypertension; a preliminary communication.
Topics: Communication; Hypertension; Iproniazid; Niacin; Nicotinic Acids | 1958 |
[Experiences with the use of Tonostan tablets].
Topics: Humans; Hypertension; Niacin; Nicotinic Acids; Tablets; Theobromine | 1961 |
THE FIBRINOLYTIC RESPONSE TO NICOTINIC ACID IN ABNORMAL LIVER STATES.
Topics: Fibrinolysis; Humans; Hypertension; Hypertension, Portal; Injections; Liver Cirrhosis; Liver Functio | 1963 |
[REHABILITATION IN HEART DISEASE].
Topics: Acenocoumarol; Dipyridamole; Electrocardiography; Geriatrics; Heart Defects, Congenital; Heart Disea | 1963 |
[DIABETES MELLITUS AND EYE CHANGES].
Topics: Adenosine Triphosphate; Animals; Blood Pressure Determination; Diabetes Mellitus, Experimental; Diab | 1963 |
[PHYSIOPATHOLOGY OF CIRCULATION IN THE VISCERAL AREA].
Topics: Abdomen; Anemia; Angiotensins; Antihypertensive Agents; Blood Circulation; Bradykinin; Coronary Vess | 1963 |
[EMBOLISM OF THE TERMINAL AORTA OPPORTUNELY TREATED WITH SODIUM NICOTINATE].
Topics: Aorta; Aorta, Abdominal; Aortic Diseases; Atrial Fibrillation; Embolism; Humans; Hypertension; Mitra | 1963 |
[SODIUM NITROPRUSSIATE IN TREATMENT OF HYPERTENSIVE ENCEPHALOPATHY DUE TO RENAL INSUFFICIENCY].
Topics: Angiography; Antihypertensive Agents; Coma; Cyanides; Electrocardiography; Humans; Hypertension; Hyp | 1964 |
THE PATHOGENESIS OF CEREBRAL VASCULAR DISEASE.
Topics: Acetylcholine; Adolescent; Cerebrovascular Disorders; Dogs; Hematoma; Hematoma, Subdural; Hypertensi | 1964 |
[CLINICO-THERAPEUTIC EXPERIENCE WITH NIACIN METHOXYPROFILINATE].
Topics: Dermatology; Gangrene; Hypertension; Intermittent Claudication; Niacin; Nicotinic Acids; Ophthalmolo | 1964 |
[STUDIES ON THE INFLUENCING OF FAT CLEARANCE IN VIVO].
Topics: Adenosine Triphosphate; Arteriosclerosis; Dietary Fats; Heparin; Hyperlipidemias; Hypertension; Iodi | 1964 |
[INDIRECT FIBRINOLYTIC AND ANTICOAGULANT TREATMENT OF THROMBOSIS].
Topics: Anticoagulants; Arteriosclerosis Obliterans; Arteritis; Coronary Disease; Diabetic Angiopathies; Eth | 1964 |
[CLINICAL STUDY OF TETRANICOTINOYLFRUCTOSE IN THE TREATMENT OF PERIPHERAL ANGIOPATHIES].
Topics: Amputation Stumps; Anticoagulants; Biomedical Research; Fructose; Humans; Hypertension; Niacin; Nico | 1964 |
[COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
Topics: Arteriosclerosis; Biomedical Research; Blood Circulation; Cerebrovascular Circulation; Cerebrovascul | 1964 |
[ON THE CLINICAL VALUE OF COLLATERAL TROPHO-ENZYMATIC THERAPY IN ACUTE AND CHRONIC HEART DISEASES].
Topics: Coenzymes; Coronary Disease; Heart Diseases; Humans; Hypertension; Khellin; Niacin; Niacinamide; Pul | 1964 |
[Effect of nicotinic hexa-ester of m-inosite (Exantene) in menopausal hypertension].
Topics: Climacteric; Female; Hexosaminidase A; Humans; Hypertension; Inositol; Menopause; Niacin; Nicotinic | 1952 |
Acute poisoning with a herbicide containing imazapyr (Arsenal): a report of six cases.
Topics: Adult; Aged; Alcoholism; Child, Preschool; Depressive Disorder; Female; Glasgow Coma Scale; Herbicid | 1999 |
[Lipid and non-lipid effects of enduracin in patients with arterial hypertension].
Topics: Blood Flow Velocity; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Female; Humans; | 1999 |
Impairment of kynurenine metabolism in cardiovascular disease.
Topics: Animals; Antihypertensive Agents; Cardiomyopathies; Cells, Cultured; Humans; Hypertension; Isoniazid | 1991 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; | 1985 |
Effect of chronic dietary treatment with nicotinic acid on the development and maintenance of deoxycorticosterone-acetate-salt-induced hypertension.
Topics: Animals; Body Weight; Desoxycorticosterone; Diet; Female; Hypertension; Niacin; Rats; Rats, Inbred S | 1988 |
Serum electrolytes in hospitalized pellagra alcoholics.
Topics: Adult; Alcoholism; Anemia; Case-Control Studies; Electrolytes; Female; Hospitalization; Humans; Hype | 2000 |
[Skin manifestation of internal diseases].
Topics: Adjustment Disorders; Adolescent; Adult; Arteriosclerosis; Child; Female; Humans; Hypertension; Lupu | 1979 |